查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917728

神经復健设备市场－2026年至2031年预测

Neurorehabilitation Devices Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计神经復健设备市场将从 2025 年的 18.57 亿美元成长到 2031 年的 36.79 亿美元，复合年增长率为 12.07%。

神经復健设备市场正稳定扩张，其主要驱动力是临床上迫切需要帮助神经系统疾病和损伤患者恢復功能、改善生活品质。这一增长得益于多项持久的人口和技术趋势，使该市场成为现代神经系统疾病护理和功能復健的关键组成部分。

市场基本驱动因素与成长因素

市场主要受非週期性因素支撑，其中最主要的是全球人口老化，这与中风、帕金森氏症、阿兹海默症神经系统疾病以及老龄化相关性认知衰退等疾病发病率的上升密切相关。这种人口结构变化正在持续推动对认知训练、运动復健和维持独立生活能力等辅助技术的需求。

同时，市场成长受到医疗基础设施不断扩张和专业化的推动，特别是专业復健设施的建立，这些设施需要各种先进设备来提供全面的护理，从而为设备引进和整合到临床管道创造了持续的机会。

技术创新仍然是最具活力的成长要素。市场特点是融合了机器人、脑机介面 (BCI)、非侵入式神经刺激和穿戴式感测器等先进技术。这些设备正从辅助角色发展成为积极推动标靶、迭代和数据驱动治疗的关键工具。一个特别重要的趋势是将人工智慧 (AI) 和数据分析技术整合到这些平台中。 AI 演算法分析患者的治疗数据，即时个人化治疗通讯协定，优化復健策略，并为临床医生提供可操作的见解，从而提高治疗效果和效率，最终实现精准的復健目标。

市场区隔与竞争格局

市场按设备类型、应用、最终用户和地区进行细分。主要设备类别包括神经机器人系统（外骨骼和復健机器人）、脑机介面、用于监测和刺激的穿戴式装置、非侵入式刺激器（例如经颅磁刺激）以及用于神经復健的游戏系统。最终用户包括医院、门诊诊所、专业復健中心以及日益增长的居家医疗机构，凸显了对便携性、易用性和远端监测设备的需求。

竞争格局由大型多元化医疗技术公司和创新专业企业共同构成。像雅培这样的领导企业利用其神经调控技术专长，提供用于治疗慢性疼痛和运动障碍的植入式和体外神经刺激设备。像Bioness Inc.这样的专业公司专注于用于肢体復健的可穿戴功能性电刺激（FES）系统，而像Ekso Bionics Holdings, Inc.这样的先锋企业则凭藉用于步态训练和运动功能恢復的机器人外骨骼技术引领行业。这些主要企业透过持续创新、策略伙伴关係以及对其技术的深入临床检验，保持显着的市场份额，从而造就了充满活力且竞争激烈的产业环境。

区域展望：北美主导潮流

北美在全球神经復健设备市场占据主导地位。这项优势源自于多面向因素的共同作用：完善且先进的医疗保健基础设施，为临床应用和研发提供了有力支持；大规模的老龄人口中神经系统疾病的高发生率；以及历来支持复杂创新医疗技术整合的监管和报销环境。此外，该地区还汇集了许多主要市场参与企业和学术研究中心，从而建立了一个有利于技术进步和商业化的强大生态系统。

未来展望及战略意义

受人口老化这一不可逆转的人口趋势以及慢性神经系统疾病负担日益加重的推动，市场预计将持续成长。机器人技术、人工智慧、感测器技术和神经科学的持续整合有望催生出更聪明、更灵活、更易用的新一代復健工具。这些进步将进一步模糊临床照护和居家照护之间的界限，从而实现以数据为导向的长期治疗方案。

未来，产业相关人员的成功不仅取决于技术水平，还取决于他们能否展现出明确的临床效用、成本效益以及改善患者预后的能力。能够无缝融入临床工作流程、提供可量化的进展指标并支持向以金额为准医疗模式转型的设备将占据尤为有利的地位。随着人们越来越关注长期功能恢復和生活质量，神经復健设备将在神经系统疾病的连续治疗中发挥日益重要的作用，使復健从辅助服务转变为以技术为支撑的核心治疗支柱。

本报告的主要优势

  • 深入分析：获取主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直细分市场和其他子细分市场。
  • 竞争格局：了解全球主要参与企业的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索市场驱动因素和关键趋势，以及它们将如何塑造未来的市场发展。
  • 可操作的建议：利用这些见解，在动态环境中製定策略决策，发展新的业务流和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021-2025年实际数据，2026-2031年预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、重大发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 神经復健设备市场（依类型划分）

  • 介绍
  • 神经机器人系统
  • 脑机介面
  • 穿戴式装置
  • 非侵入性刺激器
  • 神经復健游戏系统
  • 其他的

第六章 依应用分類的神经復健设备市场

  • 介绍
  • 中风
  • 脊髓损伤
  • 创伤性脑损伤
  • 帕金森氏症
  • 脑性麻痹
  • 其他的

第七章 依最终使用者分類的神经復健设备市场

  • 介绍
  • 医院
  • 诊所
  • 復健中心
  • 居家照护环境

第八章 各地区神经復健设备市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Medtronic plc
  • Abbott Laboratories
  • Ekso Bionics Holdings, Inc.
  • Bionik Laboratories Corp.
  • 圣犹达医疗（雅培实验室的子公司）
  • Hocoma AG（DIH International Limited 的子公司）
  • ReWalk Robotics Ltd.
  • Tyromotion GmbH
  • Kinova Robotics
  • Reha-Stim Medtec GmbH & Co. KG

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615681

The neurorehabilitation devices market, with a 12.07% CAGR, is expected to grow to USD 3.679 billion in 2031 from USD 1.857 billion in 2025.

The neurorehabilitation devices market is experiencing steady expansion, driven by the urgent clinical need to improve functional recovery and quality of life for individuals suffering from neurological conditions and injuries. This growth is underpinned by several enduring demographic and technological trends, positioning the market as a critical component of modern neurological care and functional restoration.

Fundamental Market Drivers and Growth Catalysts

The market's foundation is supported by powerful, non-cyclical drivers. The global ageing population is a primary factor, as advanced age correlates strongly with a higher incidence of neurological disorders such as stroke, Parkinson's disease, Alzheimer's, and age-related cognitive decline. This demographic shift creates sustained demand for technologies that aid in cognitive training, motor function recovery, and the maintenance of independence.

Concurrently, the ongoing expansion and specialization of healthcare infrastructure, particularly the establishment of dedicated rehabilitation facilities, fuel market growth. These centers require a diverse array of advanced equipment to deliver comprehensive care, presenting continuous opportunities for device adoption and integration into clinical pathways.

Technological innovation remains the most dynamic growth vector. The market is characterized by the integration of sophisticated technologies including robotics, brain-computer interfaces (BCIs), non-invasive neurostimulation, and wearable sensors. These devices are moving beyond supportive roles to become active facilitators of targeted, repetitive, and data-informed therapy. A particularly significant trend is the integration of artificial intelligence (AI) and data analytics into these platforms. AI algorithms can analyze patient performance data to personalize therapy protocols in real-time, optimize rehabilitation strategies, and provide clinicians with actionable insights, thereby enhancing treatment efficacy and efficiency towards precision rehabilitation goals.

Market Segmentation and Competitive Landscape

The market is segmented by device type, application, end-user, and geography. Key device categories include neurorobotic systems (exoskeletons and rehabilitation robots), brain-computer interfaces, wearable devices for monitoring and stimulation, non-invasive stimulators (e.g., Transcranial Magnetic Stimulation), and neurorehabilitation gaming systems. End-users span hospitals, outpatient clinics, specialized rehabilitation centers, and an increasingly important home-care setting, which emphasizes the need for devices that are portable, user-friendly, and suitable for remote monitoring.

The competitive landscape features a mix of large, diversified medical technology corporations and specialized innovators. Major players like Abbott Laboratories leverage their expertise in neuromodulation, offering implantable and external neurostimulation devices for chronic pain and mobility disorders. Specialized companies such as Bioness Inc. focus on wearable functional electrical stimulation (FES) systems for limb rehabilitation, while pioneers like Ekso Bionics Holdings, Inc. lead in robotic exoskeleton technology for gait training and motor recovery. These key players hold significant market share through continuous innovation, strategic partnerships, and deep clinical validation of their technologies, contributing to a dynamic and competitive industry environment.

Geographical Outlook: North American Leadership

North America maintains a dominant position in the global neurorehabilitation devices market. This leadership is attributed to a confluence of factors: a well-established and advanced healthcare infrastructure that supports both clinical adoption and research & development; a high prevalence of neurological conditions within a sizable ageing population; and a regulatory and reimbursement environment that, while complex, has historically supported the integration of innovative medical technologies. Furthermore, the region is home to many leading market players and academic research centers, fostering a robust ecosystem for technological advancement and commercialization.

Future Trajectory and Strategic Importance

The market is poised for continued growth, propelled by the irreversible demographic trends of population ageing and the rising burden of chronic neurological disorders. The ongoing convergence of robotics, AI, sensor technology, and neuroscience is expected to yield a new generation of smarter, more adaptive, and more accessible rehabilitation tools. These advancements will further blur the lines between clinical and home-based care, enabling longer-term, data-driven therapy regimens.

Future success for industry participants will hinge on demonstrating not only technical sophistication but also clear clinical utility, cost-effectiveness, and improved patient outcomes. Devices that seamlessly integrate into clinical workflows, provide quantifiable progress metrics, and support the shift towards value-based care models will be particularly well-positioned. As the focus on long-term functional recovery and quality of life intensifies, neurorehabilitation devices will play an increasingly indispensable role in the continuum of neurological care, transforming rehabilitation from a supportive service into a central, technology-enabled therapeutic pillar.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Neurorehabilitation Devices Market Segmentation

  • By Type
  • Neurorobotic Systems
  • Brain-Computer Interfaces
  • Wearable Devices
  • Non-Invasive Stimulators
  • Neurorehabilitation Gaming Systems
  • Others
  • By Application
  • Stroke
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Parkinson's Disease
  • Cerebral Palsy
  • Others
  • By End-User
  • Hospitals
  • Clinics
  • Rehabilitation Centers
  • Home Care Settings
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Neurorobotic Systems
  • 5.3. Brain-Computer Interfaces
  • 5.4. Wearable Devices
  • 5.5. Non-Invasive Stimulators
  • 5.6. Neurorehabilitation Gaming Systems
  • 5.7. Others

6. NEUROREHABILITATION DEVICES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Stroke
  • 6.3. Spinal Cord Injury
  • 6.4. Traumatic Brain Injury
  • 6.5. Parkinson's Disease
  • 6.6. Cerebral Palsy
  • 6.7. Others

7. NEUROREHABILITATION DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Clinics
  • 7.4. Rehabilitation Centers
  • 7.5. Home Care Settings

8. NEUROREHABILITATION DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Medtronic plc
  • 10.2. Abbott Laboratories
  • 10.3. Ekso Bionics Holdings, Inc.
  • 10.4. Bionik Laboratories Corp.
  • 10.5. St. Jude Medical (a subsidiary of Abbott Laboratories)
  • 10.6. Hocoma AG (a subsidiary of DIH International Limited)
  • 10.7. ReWalk Robotics Ltd.
  • 10.8. Tyromotion GmbH
  • 10.9. Kinova Robotics
  • 10.10. Reha-Stim Medtec GmbH & Co. KG

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations